Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15565
Abstract: Although myasthenia gravis (MG) is recognized as an immunoglobulin G autoantibody‐mediated disease, the relationship between autoantibody levels and disease activity in MG is unclear. We sought to evaluate this landscape through systematically assessing the evidence,… read more here.
Keywords: levels biomarkers; autoantibody; biomarkers management; myasthenia gravis ... See more keywords